The following manuscript was accepted for publication in Pharmaceutical Sciences. It is assigned to an issue after technical editing, formatting for publication and author proofing Citation: Eslamkhah S, Alizadeh N, Hajiasgharzadeh K, Eslamkhah M, Mokhtarzadeh A, Baradaran B. The clinical characteristics and treatment approaches of COVID-19: a concise review, Pharm Sci. 2021, doi: 10.34172/PS.2021.6 The clinical characteristics and treatment approaches of COVID-19: a concise review Running title: COVID-19 characteristics and treatment Sajjad Eslamkhah1≠, Nazila Alizadeh1≠, Khalil Hajiasgharzadeh1, Masoud Eslamkhah2, Ahad Mokhtarzadeh1, Behzad Baradaran1,3,4* 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 2Islamic Azad University Central Tehran Branch, Tehran, Iran. 3Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 4Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ≠ These authors contributed equally to this work. * Corresponding author: Behzad Baradaran, PhD Immunology Research Center Tabriz University of Medical Sciences Daneshghah Ave, Tabriz, Iran. E-mail address:
[email protected] 1 Abstract A series of cases of pneumonia occurred in China in late 2019. For this type of coronavirus, the WHO formally identified the condition as a coronavirus disease 2019 (COVID-19). They announced that this disease is the recent main concern of health problems in the world. Transfer of this novel coronavirus (nCoV) from human to human exists predominantly among family members, who have close contact with each other. This review article is provided based on the recent findings of COVID- 19, which were retrieved by searching PubMed, Google Scholar, Scopus, and Web of Science until December 2020.